Dr Reddy's Labs Srikakulam facility gets EIR from USFDA Ruchika Sharma22 Oct 2025 11:30 AM ISTHyderabad: Dr Reddy's Labs has announced that the Company has received the Establishment Inspection Report (EIR) from the United States Food...
AbbVie concludes acquisition of Gilgamesh Pharma Bretisilocin Ruchika Sharma21 Oct 2025 3:00 PM ISTNorth Chicago: AbbVie has announced that it has completed its acquisition of Gilgamesh Pharmaceuticals' lead investigational candidate,...
Syngene International invests in peptide lab, advanced automation Ruchika Sharma21 Oct 2025 1:30 PM ISTIndia: Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced site upgrades to...
Biocon Told to Submit Detailed Toxicity, SAE Data on Semaglutide Prefilled Pen After Animal Deaths Susmita Roy21 Oct 2025 1:00 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has opined that Biocon...
CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India Susmita Roy21 Oct 2025 12:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted permission to...
Novo Nordisk inks pact with Omeros for clinical-stage MASP-3 inhibitor zaltenibart Ruchika Sharma21 Oct 2025 12:30 PM ISTDenmark: Novo Nordisk and Omeros Corporation have announced that they have entered into a definitive asset purchase and license agreement for the...
Boehringer Ingelheim, AimedBio collaborate to develop ADC therapy for cancer Ruchika Sharma21 Oct 2025 11:59 AM ISTBoehringer Ingelheim and AimedBio, a biotechnology company specializing in the development of antibody-based therapeutics, have announced a global...
CDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis Susmita Roy20 Oct 2025 5:44 PM ISTNew Delhi: Citing that there is a concern of the risk of genital mycosis and urinary tract infection (UTI) with Empagliflozin, the Subject Expert...
Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufacture, Market Semaglutide Injection Susmita Roy20 Oct 2025 5:35 PM ISTNew Delhi: In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee (SEC) functional...
Boston Scientific to acquire Nalu Medical for USD 533 million Ruchika Sharma20 Oct 2025 2:15 PM ISTMarlborough: Boston Scientific Corporation has announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately...
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus Ruchika Sharma20 Oct 2025 1:00 PM ISTAstraZeneca has announced that Saphnelo (anifrolumab) has been recommended for approval in the European Union (EU) as a self-administered...
Viatris buys Aculys Pharma to expand neurology portfolio in Japan Ruchika Sharma20 Oct 2025 12:45 PM ISTPittsburgh: Viatris Inc., a global healthcare company, has announced it has acquired Aculys Pharma, Inc., a clinical-stage...
